Your doctor may order ANA testing if you have symptoms such as joint pain, fatigue, skin rashes, or other signs of an autoimmune disease. ANA testing may also be ordered if you have a family history of autoimmune diseases.
It is important to note that a positive Anti-Nuclear Antibody Testing does not necessarily mean you have an autoimmune disease, and a negative ANA test does not necessarily rule out an autoimmune disease. Your doctor will interpret your ANA test results in the context of your overall health and medical history, and may order additional tests or refer you to a specialist for further evaluation.
If the titer is low, this indicates that there are only a few ANA antibodies in your blood. This is a normal reaction that occurs when cells are turning over in the body and the contents of the nuclear compartments are being revealed to the immune system for brief periods of time.
This type of Anti-nuclear Antibody Testing is most effective in diagnosing autoimmune diseases like systemic lupus erythematosus, however, can also be used to detect other autoimmune disorders. The most common autoimmune diseases that can be tested for with ANA are lupus, Sjogren's syndrome and systemic sclerosis. In the laboratory, professionals measure patient’s ANA titer by setting up various dilutions of their sample and then looking for fluorescence on the antibody. They do this by incubating the diluted serum with rat liver and observing the fluorescence of the ANA antibodies that are bound to the rat liver.
Read More:
Also termed as an antinuclear factor, autoantibodies are produced in the human body in order to fight against the foreign particles.
“Global Anti-Nuclear Antibody (ANA) testing market is expected to strike a robust CAGR of 9.6% during the forecast period.
The valuation of the market is set to reach USD 1300.6 Mn by the end of 3023”.Free Sample Copy at https://www.marketresearchfuture.com/sample_request/3210The rising healthcare expenditure coupled with increasing awareness about autoimmune diseases is projected to propel the expansion of the Anti-Nuclear Antibody (ANA) testing market over the next couple of years.
Furthermore, the availability of funds for research & development as well as firm support extended by the governments is poised to boost the proliferation of the Anti-Nuclear Antibody (ANA) testing market through the assessment period.Anti-nuclear antibody Testing Market Competitive Dashboard:Some of the key players profiled in the report are Abcam plc.
North America is currently holding a dominant share of the global market and is prognosticated to expand significantly during the forecast period.
It is projected to scale new heights in the upcoming years.
Antinuclear antibodies are autoantibodies that bind to the nucleus unique contents in the cell.
Antinuclear antibody (ANA) is also termed as fluorescent antinuclear antibody (FANA) and antinuclear antibody screen.
The antibody test helps to detect the autoantibodies found in the blood serum of humans and indirect immunofluorescence and enzyme-linked immunosorbent assay test is considered as the most common ASA test.Antinuclear antibody test market is expected to gain market growth in the forecast period of 2020 to 2027.
Data Bridge Market Research analyses the market is growing at a CAGR of 12.10% in the above-mentioned period.
The increasing number of autoimmune diseases will help in escalating the growth of the antinuclear antibody test market.Click Here to Get Sample Report of Anti-nuclear Antibody Test market @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-antinuclear-antibody-test-marketMarket Drivers and Restraints:On the basis of product, the antinuclear antibody test market is segmented into reagents & assay kits, systems, and software & services.On the basis of disease, the antinuclear antibody test market is segmented into rheumatoid arthritis, systemic lupus erythematosus, sjögren’s syndrome, scleroderma, and other diseases.On the basis of technique, the antinuclear antibody test market is segmented into ELISA, immunofluorescence assay, and multiplex assay.On the basis of end users, the antinuclear antibody test market is segmented into hospitals, clinical laboratories, physician office laboratories, and others end users.The major players covered in the Anti-nuclear Antibody Test MarketThe major players covered in the antinuclear antibody test market report are Alere Inc., Bio-Rad Laboratories, ERBA Diagnostics, Trinity Biotech, Thermo Fisher Scientific, Inc., Antibodies Incorporated, Euroimmun, Immuno Concepts N.A.
Ltd., Inova Diagnostics, Inc., ZEUS Scientific, Inc., Grifols, S.A, Abbott Laboratories, BioVision, Inc., PerkinElmer, BD, Roche Holding AG, Inova Diagnostics, Inc., Alere Inc., and Euroimmun among other domestic and global players.
Antinuclear antibody test market is expected to gain market growth in the forecast period of 2020 to 2027.
Data Bridge Market Research analyses the market is growing at a CAGR of 12.10% in the above-mentioned period.
The increasing number of autoimmune diseases will help in escalating the growth of the antinuclear antibody test market.Antinuclear antibodies are autoantibodies that bind to the nucleus unique contents in the cell.
Antinuclear antibody (ANA) is also termed as fluorescent antinuclear antibody (FANA) and antinuclear antibody screen.
The antibody test helps to detect the autoantibodies found in the blood serum of humans and indirect immunofluorescence and enzyme-linked immunosorbent assay test is considered as the most common ASA test.See the COVID-19 Significant Impact and Post Opportunities | Download Sample Reporthttps://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-antinuclear-antibody-test-marketMarket Drivers and Restraints:On the basis of product, the antinuclear antibody test market is segmented into reagents & assay kits, systems, and software & services.On the basis of disease, the antinuclear antibody test market is segmented into rheumatoid arthritis, systemic lupus erythematosus, sjögren’s syndrome, scleroderma, and other diseases.On the basis of technique, the antinuclear antibody test market is segmented into ELISA, immunofluorescence assay, and multiplex assay.On the basis of end users, the antinuclear antibody test market is segmented into hospitals, clinical laboratories, physician office laboratories, and others end users.The major players covered in the Antinuclear Antibody Test Market The major players covered in the antinuclear antibody test market report are Alere Inc., Bio-Rad Laboratories, ERBA Diagnostics, Trinity Biotech, Thermo Fisher Scientific, Inc., Antibodies Incorporated, Euroimmun, Immuno Concepts N.A.
Ltd., Inova Diagnostics, Inc., ZEUS Scientific, Inc., Grifols, S.A, Abbott Laboratories, BioVision, Inc., PerkinElmer, BD, Roche Holding AG, Inova Diagnostics, Inc., Alere Inc., and Euroimmun among other domestic and global players.
